GENINUS Inc. (389030.KQ) — Stock Score Summary

GENINUS Inc. (389030.KQ) has a MoatMap StockRank of 21/100 based on Quality (26/100), Value (45/100), and Momentum (36/100) factor scores. The current signal is SELL.

GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia.

Key Financial Metrics

Price$1.88
Market Cap$74M
Price/Book10.44
Return on Equity-71.9%
Return on Invested Capital-155.0%
Debt/Equity34.08
Gross Margin3.2%
Operating Margin-85.8%
Revenue Growth-9.2%
Free Cash Flow$4K

GENINUS Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is GENINUS Inc.’s (389030.KQ) StockRank?
MoatMap’s StockRank for GENINUS Inc. (389030.KQ) is 21/100, with a Sell signal. It is a composite of Quality (26), Value (45), and Momentum (36) factor ranks across MoatMap’s 19,000+ stock universe.
Does GENINUS Inc. have an economic moat?
GENINUS Inc. (389030.KQ) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is GENINUS Inc. a buy, hold, or sell?
MoatMap’s current signal for GENINUS Inc. (389030.KQ) is Sell, based on a StockRank of 21/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is GENINUS Inc. in?
GENINUS Inc. (389030.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks389030.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock